| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 Aug 2025 | 29 Jul 2025 |
| Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve the unaudited financial results (standalone) of the Company for the quarter ended on June 30 2025. 1. Considered and approved the Un-audited financial results of the company for the quarter ended 30th June 2025. 2. Appointment of M/s. SBR & Co. LLP, Company Secretaries (LLP No. AAO-9057) as the Secretarial Auditors of the Company for Financial year 25-30. 3. Considered and approved the appointment of Mr. Navjyoti Kumar Jha as Internal Auditor of the company for the F.Y. 2025-26. 4. Re-appointment of Mr. Yogesh Agrawal as Chairman & Managing Director of the Company for the period of five (5) years with effect from 07.09.2025. Considered and approve the unaudited financial results for the quarter ended June 30, 2025 along with limited review report. Considered and approved the appointment of Mr. Navjyoti Kumar Jha as internal auditor of the company for the FY 2025-26. (As per BSE Announcement Dated on 07.08.2025) | ||
| Board Meeting | 30 May 2025 | 22 May 2025 |
| Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the audited financial results (standalone) of the Company for the quarter and year ended March 31 2025. 1. Considered and approved the standalone audited financial results of the company for the quarter and financial year ended 31st March 2025. 2. Appointment of Mr. Yogainder Kumar Gupta (DIN: 03094998) as an Additional Director in the category of Non-Executive - Independent Director on the Board of Directors of the Company w.e.f., Friday, 30th May, 2025 to hold office for a term of 5 (five) consecutive years upto May 29, 2030, subject to the approval of the shareholders in the General Meeting. 3. Appointment of M/s. SBR & Co. LLP, Company Secretaries (LLP No. AAO-9057) as the Secretarial Auditors of the Company for Financial year 24-25. 4. Considered Reconstitution of the Committees - Audit Committee, Stakeholders Relationship Committee (SRC), Nomination and Remuneration Committee (NRC), Risk Management Committee as per the provisions of the Companies Act, 2013 and the SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 30/05/2025) | ||
| Board Meeting | 14 Feb 2025 | 10 Feb 2025 |
| Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve This is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Friday 14th February 2025. Outcome of the Board Meeting pursuant to Regulation 30 held today i.e. 14th February, 2025 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement Dated on: 14/02/2025) | ||
| Board Meeting | 6 Dec 2024 | 2 Dec 2024 |
| Inter alia, to consider the following items: a) To consider and Approve the Directors Report of the Board of Director of the company for the Financial Year 2023-24. b) To Consider and Approve the date, time, venue and mode for convening the 30th Annual General Meeting of the Company. c) To consider and approve to appoint SBR & Co. LLP, Company Secretaries, as Scrutinizer for the ensuing Annual General Meeting. d) To consider any other business with the permission of the chair Please Find enclosed herewith the Outcome of the Board Meeting dated 06/12/2024 for your reference. (As Per BSE Announcement dated on 06.12.2024) | ||
| Board Meeting | 7 Oct 2024 | 3 Oct 2024 |
| Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2024 inter alia to consider and approve Please find enclosed herewith the Intimation of Board meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations2015 Please find enclosed herewith Outcome of Board Meeting Pusuant to regulation 30 of Sebi ( LODR)Regulation ,2015 held on today i.e. 07th October 2024 (As per BSE Announcement Dated on 07/10/2024) | ||
| Board Meeting | 5 Sep 2024 | 6 Sep 2024 |
| Outcome of Board Meeting held on September 05, 2024 | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.